HOLD with staged entry preferred; cap position at 2% max, add only on pullbacks to $100-103, maintain $103 hard stop, trim aggressively above $115

• PEG ratio of 1.13 is computed off 42% EPS growth entirely fueled by rate environment; forward EPS estimate of $7.80 bakes in continuation of current conditions rather than normalized environment
• Vanguard's $4 billion Altruist platform signals structural repricing of brokerage ecosystem; multiples on capital-markets franchises compress from competitive uncertainty before revenue declines
• Technical breakdown shows late-stage distribution: 33% rally ending in gap-down open, loss of both 10 EMA and 30-day VWMA, fresh MACD bearish crossover, 2x average volume distribution day
• Buyback support is programmatic quarterly execution providing support but not immunity; March 2020 and September 2022 saw continued buybacks alongside 30-40% drawdowns
• Risk/reward asymmetry is misrepresented by point estimates: realistic distribution is 50% probability of weakness to $103-106, 35% chance of basing at $108-112, only 15% chance of breakout to $125
• Position sizing at 4% doubles capital at risk on name with technical cracks, competitive narrative shift, and pricing near 52-week highs
• Target of $130-135 requires multiple expansion via either falling rates (which compresses NII) or regime change in equity leadership toward quality compounders—bull case scenario
• Polymarket pricing of 87% odds for zero rate cuts is crowded positioning with asymmetric downside; any dovish pivot signal immediately reprices SCHW's NII lower
• Hard stop at $103 is appropriate capital protection; aggressive analyst's argument against stops advocates unlimited downside tolerance
• Quality assets bought after technical breakdowns produce better returns than quality assets bought at wrong prices during elevated risk environments

→ vs aggressive: PEG argument uses 1.13-1.4 ratio anchored to 42% rate-fueled growth; when rates normalize, earnings base resets and multiple must adjust downward, not a valid basis for current entry

→ vs aggressive: Vanguard-Altruist dismissal of 0.1% of AUM misses structural narrative shift; $4 billion investment in technology is a multi-year competitive threat that compresses multiples before revenue declines

→ vs aggressive: Technical 'profit-taking' framing ignores textbook late-stage distribution: MACD bearish crossover, 2x volume distribution day, and loss of 10 EMA and 30-day VWMA are not routine breather patterns

→ vs aggressive: Buyback floor argument treats programmatic quarterly execution as price immunity; historical precedent shows 30-40% drawdowns occurred in March 2020 and September 2022 despite continued buybacks

→ vs aggressive: Risk/reward of 2.5:1 uses point estimates rather than probability-weighted outcomes; realistic distribution is 50%/35%/15% versus stated symmetric probabilities

→ vs aggressive: Position sizing at 3-4% doubles capital at risk versus trader's 2-3% on single name with technical cracks, competitive uncertainty, and 52-week high pricing

→ vs aggressive: Target of $130-135 requires multiple expansion on top of normalized growth and buyback accretion—bull case outcome requiring everything to go right, not base case

→ vs aggressive: Macro positioning for 87% zero-cut probability is crowded trade with asymmetric downside; any deviation immediately reprices NII lower while positioning for zero cuts yields no upside

→ vs aggressive: Argument that $103 hard stop is too tight because beta of 0.75 causes shakeout is backwards; stops protect capital from extended breakdowns regardless of recovery potential

Stage entry in $105-107 zone over 3-4 weeks; 2.5% initial position (3% on confirmation); closing stop at $102; trim 25% at $118-120, 25% at $125, hold remainder to $130+; small hedge via VIX calls or SCHW puts given suppressed VIX at 15; await Q3 earnings ($1.65+ EPS) for bull case confirmation.

• 12-month base case target $122-125; bull case $128-132 if multiple expansion materializes
• Forward P/E closer to 13.5x at $105-107 entry on conservative estimates
• $7.80 forward EPS with 15x multiple gives $117 downside to current price; thesis not broken, upside more bounded
• Position sizing: 2.5% initial deployment, scaling to 3% on confirmation (1.5x benchmark at base case)
• Stage orders in $105-107 zone over 3-4 weeks; accept missing entry if not reached
• Buybacks: $3.05 billion executed last quarter, approximately 1.6% of market cap per quarter, 6%+ annualized (programmatic, price-agnostic)
• Technical: RSI reset to 55.99 (neutral, not bearish); MACD histogram at -0.22 (barely negative on single session); 50/200 SMA spread at 6 points with both rising
• 50 SMA acting as dynamic support; price held above it on breakdown day
• ATR at 2.29; volatility-adjusted stop 2.5 ATR from $107.50 entry = $101.78
• Closing stop at $102 (below 50 SMA on close, not intraday); $104-105 intraday prints are normal and not stop-worthy
• 10 EMA reclaim at $110.65 on closing basis is legitimate signal to add above initial position
• VIX suppressed at 15; asymmetric payoff on VIX call spreads or SCHW puts if vol regime shifts
• Q3 earnings in October is key validation point; EPS $1.65+ with NII strength and stable client cash sorting confirms bull case
• High-rate regime has been consensus; each quarter funds rate held steady is another quarter of NII expansion
• Conservative analyst's 50% probability for further weakness is overweighted; neutral weights 30% weakness, 45% basing, 25% upside

→ vs aggressive: Overstates opportunity cost of waiting; $105-107 entry vs $109 adds ~5% to multi-year return without materially changing exposure on a 12-month horizon. Also sloppy in dismissing the 10 EMA reclaim at $110.65 as a 'green light that comes after you've missed the move' — it's a legitimate signal to add if already in.

→ vs aggressive: False dichotomy framing 'buy now at $109 or miss the entire move' ignores that SCHW is not a binary 'you got it or you didn't' trade; a 4-6% pullback entry meaningfully compounds over 3-5 year holding period.

→ vs conservative: Probability distribution is too bearish; 50% weighting for further weakness is anchored on August 26 technical damage being more significant than it actually was. Single bearish MACD cross after 33% rally in 3 months is not a trend break. Neutral assigns 30% weakness, 45% basing, 25% upside resolution.

→ vs conservative: Conflating hard stop below structural support with prudent risk management; $103 hard stop implemented as intraday stop gets stopped out at worst moment if stock trades to $102.50 before recovering. Should be closing-price stop at $102 instead.

→ vs conservative: Macro call on 87% Polymarket zero-cut odds as 'crowded trade with asymmetric downside' is backwards; if 87% positioned for zero cuts and we get zero cuts nothing changes, but each quarter with rates held steady benefits SCHW NII expansion. Asymmetry favors long side given consensus has been high-rate for nine months.

→ vs conservative: Vanguard-Altruist narrative is a sentiment overhang limiting multiple expansion near-term but doesn't change fundamental earnings trajectory; argues for 15x multiple (not 17x) yielding $117 target, which is still near current price, not a thesis-breaking event.